Influenza

Showing NaN - NaN of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

Influenza Trial in United States (mRNA-1010, mRNA-1010.4, mRNA-1010.6)

Recruiting
  • Influenza
  • mRNA-1010
  • +2 more
  • Hollywood, Florida
  • +9 more
May 11, 2023

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

Influenza, Influenza -Like Illness Trial in United States (Norketotifen, Placebo)

Completed
  • Influenza
  • Influenza -Like Illness
  • Phoenix, Arizona
  • +19 more
Jan 25, 2023

Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)

Recruiting
  • Influenza
  • Baloxavir Marboxil
  • Placebo
  • Birmingham, Alabama
  • +290 more
Jan 20, 2023

Influenza Trial in Worldwide (VIS410 low dose, VIS410 high dose, Placebo)

Completed
  • Influenza
  • VIS410 low dose
  • +2 more
  • Huntsville, Alabama
  • +53 more
Aug 11, 2022

Influenza Trial in United States (Quadrivalent influenza vaccine, high-dose, Quadrivalent influenza vaccine, standard dose)

Suspended
  • Influenza
  • Quadrivalent influenza vaccine, high-dose
  • Quadrivalent influenza vaccine, standard dose
  • San Diego, California
  • +9 more
May 3, 2022

Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),

Completed
  • Influenza
  • High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
  • +4 more
  • San Diego, California
  • +15 more
Mar 24, 2022

Influenza Trial in United Kingdom, United States (Fluzone Quadrivalent vaccine, No Preservative)

Completed
  • Influenza
  • Fluzone Quadrivalent vaccine, No Preservative
  • Birmingham, Alabama
  • +35 more
Mar 15, 2022

Influenza, Human, Virus Diseases Trial in United States (QIVc, Comparator QIV)

Completed
  • Influenza
  • +2 more
  • QIVc
  • Comparator QIV
  • Mobile, Alabama
  • +46 more
Dec 13, 2021

HIV, Influenza Trial in Puerto Rico, United States (Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated

Completed
  • HIV Infections
  • Influenza
  • Cold-adapted live attenuated influenza vaccine (FluMist)
  • Inactivated influenza vaccine (IAIV)
  • Birmingham, Alabama
  • +60 more
Oct 28, 2021

Influenza Trial in Worldwide (Liquid CAIV-T)

Completed
  • Influenza
  • Liquid CAIV-T
  • Hoover, Alabama
  • +160 more
Sep 10, 2021

Influenza Trial in United States (Peramivir)

Completed
  • Influenza
  • Brooksville, Florida
  • +14 more
Feb 26, 2021

Influenza Trial in United States (Peramivir, Placebo)

Terminated
  • Influenza
  • Millbrook, Alabama
  • +95 more
Feb 24, 2021

Influenza Trial in Miami (VAL-339851, Placebo)

Completed
  • Influenza
  • VAL-339851
  • Placebo
  • Miami, Florida
    Miami Research Associates
Jan 7, 2021

Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine

Completed
  • Pregnancy
  • Influenza
  • Quadrivalent Intradermal Influenza Vaccine (QIV)
  • San Diego, California
  • +4 more
Feb 11, 2020

Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)

Completed
  • Influenza
  • Birmingham, Alabama
  • +90 more
Jan 31, 2019

Influenza Trial in Worldwide (Influenza vaccine GSK2321138A, FluarixTM, Influenza vaccine GSK2604409A)

Completed
  • Influenza
  • Influenza vaccine GSK2321138A
  • +2 more
  • Chandler, Arizona
  • +41 more
Aug 22, 2018

Influenza Trial in Canada, United States (GSK A/turkey H5N1 Influenza vaccine)

Completed
  • Influenza
  • GSK A/turkey H5N1 Influenza vaccine
  • Huntsville, Alabama
  • +9 more
Aug 22, 2018

Influenza Trial in Canada, United States (Pumarix™, Pandemrix ™)

Completed
  • Influenza
  • Pumarix™
  • Pandemrix ™
  • Huntsville, Alabama
  • +9 more
Jul 2, 2018

Influenza Trial in Worldwide (Trivalent influenza vaccine (TIVc), Trivalent influenza vaccine-licensed)

Completed
  • Influenza
  • Trivalent influenza vaccine (TIVc)
  • Trivalent influenza vaccine-licensed
  • Phoenix, Arizona
  • +26 more
Jun 11, 2018

Influenza Trial in Canada, United States (Investigational H9N2 vaccine GSK2654911A, Investigational H9N2 vaccine GSK2654909A,

Completed
  • Influenza
  • Investigational H9N2 vaccine GSK2654911A
  • +2 more
  • Miami, Florida
  • +3 more
Jun 14, 2018

Influenza Trial in South Africa, United States (Oseltamivir, MEDI8852, Placebo)

Completed
  • Influenza
  • Canoga Park, California
  • +30 more
May 7, 2018

Influenza Trial in Miami, Lenexa (Trivalent influenza vaccine GSK 138842A, Fluarix)

Completed
  • Influenza
  • Trivalent influenza vaccine GSK 138842A
  • Fluarix
  • Miami, Florida
  • +1 more
May 9, 2018

Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)

Completed
  • Influenza
  • Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
  • Placebo
  • Huntsville, Alabama
  • +39 more
May 9, 2018